Cargando…

A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome

BACKGROUND: Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enha...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Gautam K., McClenaghan, Conor, Aggarwal, Manish, Gu, Hongjie, Remedi, Maria S., Grange, Dorothy K., Nichols, Colin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798820/
https://www.ncbi.nlm.nih.gov/pubmed/36515236
http://dx.doi.org/10.1161/JAHA.122.027363
_version_ 1784860987049902080
author Singh, Gautam K.
McClenaghan, Conor
Aggarwal, Manish
Gu, Hongjie
Remedi, Maria S.
Grange, Dorothy K.
Nichols, Colin G.
author_facet Singh, Gautam K.
McClenaghan, Conor
Aggarwal, Manish
Gu, Hongjie
Remedi, Maria S.
Grange, Dorothy K.
Nichols, Colin G.
author_sort Singh, Gautam K.
collection PubMed
description BACKGROUND: Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high‐output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. METHODS AND RESULTS: We sought to systematically characterize high‐output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain‐of‐function variants in ABCC9, which encodes cardiovascular K(ATP) (ATP‐sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3–32 years], body mass index 19.9 [16.5–22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7–103.0] g/m(2) in CS, n=30; 26.6 [24.1–32.8] g/m(2) in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90–103] mm Hg in CS, n=17; 109 [98–115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56–66] mm Hg in CS, n=17; 69 [65–72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long‐term follow‐up. CONCLUSIONS: The data define the natural history of high‐output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long‐term consequences of high‐output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high‐output heart failure.
format Online
Article
Text
id pubmed-9798820
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97988202023-01-05 A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome Singh, Gautam K. McClenaghan, Conor Aggarwal, Manish Gu, Hongjie Remedi, Maria S. Grange, Dorothy K. Nichols, Colin G. J Am Heart Assoc Original Research BACKGROUND: Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high‐output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. METHODS AND RESULTS: We sought to systematically characterize high‐output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain‐of‐function variants in ABCC9, which encodes cardiovascular K(ATP) (ATP‐sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3–32 years], body mass index 19.9 [16.5–22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7–103.0] g/m(2) in CS, n=30; 26.6 [24.1–32.8] g/m(2) in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90–103] mm Hg in CS, n=17; 109 [98–115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56–66] mm Hg in CS, n=17; 69 [65–72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long‐term follow‐up. CONCLUSIONS: The data define the natural history of high‐output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long‐term consequences of high‐output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high‐output heart failure. John Wiley and Sons Inc. 2022-12-14 /pmc/articles/PMC9798820/ /pubmed/36515236 http://dx.doi.org/10.1161/JAHA.122.027363 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Singh, Gautam K.
McClenaghan, Conor
Aggarwal, Manish
Gu, Hongjie
Remedi, Maria S.
Grange, Dorothy K.
Nichols, Colin G.
A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
title A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
title_full A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
title_fullStr A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
title_full_unstemmed A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
title_short A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
title_sort unique high‐output cardiac hypertrophy phenotype arising from low systemic vascular resistance in cantu syndrome
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798820/
https://www.ncbi.nlm.nih.gov/pubmed/36515236
http://dx.doi.org/10.1161/JAHA.122.027363
work_keys_str_mv AT singhgautamk auniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT mcclenaghanconor auniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT aggarwalmanish auniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT guhongjie auniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT remedimarias auniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT grangedorothyk auniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT nicholscoling auniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT singhgautamk uniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT mcclenaghanconor uniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT aggarwalmanish uniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT guhongjie uniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT remedimarias uniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT grangedorothyk uniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome
AT nicholscoling uniquehighoutputcardiachypertrophyphenotypearisingfromlowsystemicvascularresistanceincantusyndrome